Shares of Biocon were trading with positive momentum in Thursday's session. At 10:45 am, the stock was priced at Rs 360.20 on the NSE, a 1.65% increase from its previous close. The stock is a constituent of the Nifty Midcap 150 index, and experienced a surge in volume.
Financial Overview:
Biocon's financial performance reveals the following trends based on consolidated statements:
Quarterly Performance:
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 3,432.90 Crore | Rs 3,590.40 Crore | Rs 3,821.40 Crore | Rs 4,417.00 Crore | Rs 3,941.90 Crore |
| Net Profit | Rs 861.80 Crore | Rs 27.10 Crore | Rs 81.10 Crore | Rs 459.40 Crore | Rs 89.20 Crore |
| EPS | 5.51 | -0.13 | 0.21 | 2.88 | 0.26 |
Annual Performance:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 7,105.80 Crore | Rs 8,184.00 Crore | Rs 11,174.20 Crore | Rs 14,755.70 Crore | Rs 15,261.70 Crore |
| Net Profit | Rs 925.40 Crore | Rs 978.50 Crore | Rs 810.00 Crore | Rs 1,382.00 Crore | Rs 1,429.40 Crore |
| EPS | 6.24 | 5.44 | 3.88 | 8.55 | 8.46 |
| BVPS | 70.09 | 78.87 | 187.31 | 210.51 | 180.27 |
| ROE | 9.83 | 7.69 | 2.58 | 5.16 | 4.68 |
| Debt to Equity | 0.47 | 0.58 | 0.99 | 0.80 | 0.82 |
Cash Flow:
| Heading | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Operating Activities | Rs 4,061 Crore | Rs 2,953 Crore | Rs 1,852 Crore | Rs 1,176 Crore | Rs 1,159 Crore |
| Investing Activities | Rs -234 Crore | Rs -1,004 Crore | Rs -14,281 Crore | Rs -1,699 Crore | Rs -3,624 Crore |
| Financing Activities | Rs -1,854 Crore | Rs -2,332 Crore | Rs 13,048 Crore | Rs 242 Crore | Rs 2,564 Crore |
| Others | Rs 31 Crore | Rs 2 Crore | Rs 21 Crore | Rs 37 Crore | Rs 7 Crore |
| Net Cash Flow | Rs 2,004 Crore | Rs -380 Crore | Rs 641 Crore | Rs -243 Crore | Rs 106 Crore |
| Heading | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Share Capital | Rs 600 Crore | Rs 600 Crore | Rs 600 Crore | Rs 600 Crore | Rs 600 Crore |
| Reserves & Surplus | Rs 21,043 Crore | Rs 19,183 Crore | Rs 17,266 Crore | Rs 7,832 Crore | Rs 6,931 Crore |
| Current Liabilities | Rs 14,333 Crore | Rs 15,358 Crore | Rs 8,510 Crore | Rs 3,828 Crore | Rs 4,210 Crore |
| Other Liabilities | Rs 22,819 Crore | Rs 20,928 Crore | Rs 25,665 Crore | Rs 8,133 Crore | Rs 6,781 Crore |
| Total Liabilities | Rs 58,797 Crore | Rs 56,070 Crore | Rs 52,042 Crore | Rs 20,394 Crore | Rs 18,522 Crore |
| Fixed Assets | Rs 23,686 Crore | Rs 22,264 Crore | Rs 20,648 Crore | Rs 10,653 Crore | Rs 9,137 Crore |
| Current Assets | Rs 16,286 Crore | Rs 15,179 Crore | Rs 12,334 Crore | Rs 8,382 Crore | Rs 7,600 Crore |
| Other Assets | Rs 18,825 Crore | Rs 18,626 Crore | Rs 19,060 Crore | Rs 1,358 Crore | Rs 1,784 Crore |
| Total Assets | Rs 58,797 Crore | Rs 56,070 Crore | Rs 52,042 Crore | Rs 20,394 Crore | Rs 18,522 Crore |
| Contingent Liabilities | Rs 2,086 Crore | Rs 2,594 Crore | Rs 1,990 Crore | Rs 1,585 Crore | Rs 1,588 Crore |
| Heading | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 8.46 | 8.55 | 3.88 | 5.44 | 6.24 |
| Diluted Eps (Rs.) | 8.46 | 8.54 | 3.87 | 5.42 | 6.19 |
| Book Value [Excl. Reval Reserve]/Share (Rs.) | 180.27 | 210.51 | 187.31 | 78.87 | 70.09 |
| Dividend/Share (Rs.) | 0.50 | 0.50 | 1.50 | 0.50 | 0.00 |
| Face Value | 5 | 5 | 5 | 5 | 5 |
| Gross Profit Margin (%) | 28.66 | 28.22 | 25.84 | 26.67 | 26.83 |
| Operating Margin (%) | 17.60 | 17.58 | 15.88 | 16.72 | 16.77 |
| Net Profit Margin (%) | 9.36 | 9.36 | 7.24 | 11.95 | 12.88 |
| Return on Networth / Equity (%) | 4.68 | 5.16 | 2.58 | 7.69 | 9.83 |
| ROCE (%) | 6.04 | 6.37 | 4.07 | 8.26 | 8.32 |
| Return On Assets (%) | 1.72 | 1.82 | 0.88 | 3.17 | 3.99 |
| Current Ratio (X) | 1.14 | 0.99 | 1.45 | 2.19 | 1.81 |
| Quick Ratio (X) | 0.79 | 0.67 | 0.95 | 1.59 | 1.36 |
| Debt to Equity (x) | 0.82 | 0.80 | 0.99 | 0.58 | 0.47 |
| Interest Coverage Ratios (X) | 4.87 | 4.27 | 6.89 | 32.29 | 20.66 |
| Asset Turnover Ratio (%) | 0.27 | 0.27 | 0.31 | 0.13 | 38.36 |
| Inventory Turnover Ratio (X) | 3.09 | 1.10 | 0.98 | 0.76 | 3.81 |
| 3 Yr CAGR Sales (%) | 36.56 | 44.10 | 33.17 | 21.82 | 31.27 |
| 3 Yr CAGR Net Profit (%) | 20.86 | 22.21 | -5.12 | -1.16 | 46.39 |
| P/E (x) | 40.39 | 30.89 | 53.18 | 61.69 | 65.53 |
| P/B (x) | 1.89 | 1.60 | 1.39 | 4.76 | 6.51 |
| EV/EBITDA (x) | 13.87 | 12.17 | 15.50 | 20.32 | 26.99 |
| P/S (x) | 2.68 | 2.15 | 2.22 | 4.91 | 6.90 |
Biocon announced several corporate actions, including the intimation of a record date for the buyback of listed commercial paper issued by the company on September 17, 2025. The company also released press releases on September 17 and September 12, 2025.
The company has announced final dividends in recent years. Most recently, a dividend of Rs 0.50 per share was announced on May 8, 2025, with an effective date of July 4, 2025. Similar dividends were announced in May 2024 and April 2022. A higher dividend of Rs 1.50 per share was announced in May 2023.
Biocon has issued bonus shares in the past. A 1:1 bonus was announced on April 25, 2019, with an ex-bonus date of June 12, 2019. A 2:1 bonus was announced on April 27, 2017, and another 1:1 bonus was announced on April 22, 2008.
With the stock's last traded price at Rs 360.20, Biocon has shown positive movement amid high trading volumes in Thursday's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
